Related Experiment Video
Updated: Aug 10, 2026

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry
Published on: March 7, 2019
Beta-amyloid fibrils of Alzheimer's disease: pathologically altered, basement membrane-associated microfibrils?
1Department of Anatomy and Cell Biology, McGill Univeristy, Montreal, Quebec, Canada. mdin@musica.mcgill.ca
Abstract:
Beta amyloid fibrils were examined in situ in the cerebral cortex of brains from patients with Alzheimer's disease using high resolution ultrastructural and immunohistochemical techniques. The main body of the fibril was identical with that of microfibrils and was made up of a core containing amyloid P component (AP), and a surface layer. Beta amyloid protein (Abeta) in the form of 1 nm wide flexible filaments was associated with the external surface of the microfibril. In cerebrovascular amyloid angiopathy the fibrils were formed at the outer surface of the vascular basement membrane. Overproduction of microfibrils has been reported at the basement membrane of "leaky" capillaries including the glomerular capillary in disease or leaky alveolar-capillary walls of normal lungs. Similarly, in Alzheimer's disease overproduction of microfibril-like beta amyloid fibrils in amyloid angiopathy coincided with breakdown of the blood-brain barrier of the cerebromicrovasculature. Thus, in the above three locations, the presence of abundant microfibrils, or microfibril-like structures, may be related to plasma which leaks out of the circulation into the adjoining vascular basement membrane. AP is an essential constituent of microfibrils and since the only site where AP is available in the cerebral cortex is in leaky microvasculature, a chronic, steady supply of AP into perivascular areas may be the cause of overproduction of microfibrils. Brain "microfibrils" may further be altered pathologically into beta amyloid fibrils by the addition of Abeta. The origin of the fibrils in senile plaques may also be the microvasculature since in the area of the plaques no source of AP is apparent.
Insights
Alzheimer's disease involves beta-amyloid fibrils, similar to microfibrils, found in cerebral cortex. These fibrils contain amyloid P component and beta-amyloid protein, potentially originating from leaky blood vessels.
Area of Science:
- Neuroscience
- Pathology
- Biochemistry
Background:
- Alzheimer's disease (AD) is characterized by beta-amyloid (Abeta) fibrils in the brain.
- Cerebrovascular amyloid angiopathy (CAA) also involves Abeta deposition in blood vessels.
- Microfibrils and amyloid P component (AP) are implicated in amyloid formation.
Purpose of the Study:
- To investigate the ultrastructure and in situ formation of beta-amyloid fibrils in Alzheimer's disease.
- To explore the relationship between microfibrils, amyloid P component, and Abeta in AD and CAA.
- To determine the potential origin of beta-amyloid fibrils in the cerebral cortex.
Main Methods:
- High-resolution ultrastructural examination of brain tissue from Alzheimer's patients.
- Immunohistochemical techniques to identify specific protein components.
- In situ analysis of beta-amyloid fibril structure and localization.
Main Results:
- Beta-amyloid fibrils share structural identity with microfibrils, featuring an amyloid P component core and a surface layer.
- Flexible 1 nm filaments of beta-amyloid protein (Abeta) associate with the external surface of microfibrils.
- In CAA, fibrils form on the vascular basement membrane, coinciding with blood-brain barrier breakdown in AD.
Conclusions:
- Overproduction of microfibril-like structures in AD and CAA may stem from plasma leakage through "leaky" capillaries.
- Amyloid P component, supplied by leaky microvasculature, is crucial for microfibril overproduction.
- Beta-amyloid fibrils in senile plaques and CAA may originate from the cerebral microvasculature.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction
Alzheimer Disease ll: Pathophysiology
Dementia l: Introduction

